Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Chemoprevention by WR-2721

Conference ·
OSTI ID:6374457
 [1];  [2]
  1. Argonne National Lab., IL (United States) Chicago Univ., IL (United States). Dept. of Radiation and Cellular Oncology
  2. Argonne National Lab., IL (United States)
WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid] is an effective chemopreventive agent. C57BL [times] BALB/c F[sub 1] female mice, were exposed to a single whole-body dose of 206 cGy from a [sup 60]Co photon source. Those groups treated with VATR-2721 (400 mg/kg) were administered the agent i.p. 30 min prior to irradiation. Over 90% of deaths were determined to be due to tumor involvement. WR-2721 afforded significant protection against life shortening due to radiation-induced tumors of connective tissue and epithelial tissue origins. Subsequent survival time in WR-2721-treated and irradiated animals as compared to matched irradiated-only controls was extended up to 59 days. A single exposure of animals to VVR-2721 did not affect the cumulative survival curves for unirradiated mice. WR-2721 possesses chemopreventive properties which can be clinically exploited to reduce the risk to therapy-induced secondary cancers in patients who otherwise would have an excellent prognosis for cure and long-term survival.
Research Organization:
Argonne National Lab., IL (United States)
Sponsoring Organization:
DOE; DOHHS; USDOE, Washington, DC (United States); Department of Health and Human Services, Washington, DC (United States)
DOE Contract Number:
W-31109-ENG-38
OSTI ID:
6374457
Report Number(s):
ANL/BIM/CP-78742; CONF-9304141--1; ON: DE93012907; CNN: CA-37435
Country of Publication:
United States
Language:
English